Kyron.bio (Seed)
Funding Details
- Awarder
- RSS - tech.eu
- Date Award
- May 28, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $5,500,000
Company Info
- Traction
- Funding will accelerate the development of kyron.bio’s proprietary glycan-engineering platform, expand the team, and fuel preclinical studies.
- Founders
- Dr. Emilia McLaughlin
- Company Description
- Kyron.bio is a biotechnology company that unlocks precision control of glycans to reduce immune side effects and improve drug efficacy in antibody therapeutics.
- Market
- Biopharma
- Location
- Not specified, Not specified, Not specified
- Coinvestors
- HCVC, Verve Ventures, Entrepreneur First, Saras Capital, numerous reputable angel investors